Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Return on Equity (2021 - 2023)

Historic Return on Equity for Cullinan Therapeutics (CGEM) over the last 3 years, with Q3 2023 value amounting to 0.32%.

  • Cullinan Therapeutics' Return on Equity fell 4900.0% to 0.32% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.32%, marking a year-over-year decrease of 4900.0%. This contributed to the annual value of 0.23% for FY2022, which is 4400.0% up from last year.
  • As of Q3 2023, Cullinan Therapeutics' Return on Equity stood at 0.32%, which was down 4900.0% from 0.29% recorded in Q2 2023.
  • In the past 5 years, Cullinan Therapeutics' Return on Equity registered a high of 0.21% during Q2 2022, and its lowest value of 0.32% during Q3 2023.
  • Moreover, its 3-year median value for Return on Equity was 0.03% (2021), whereas its average is 0.03%.
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 3500bps in 2022, then plummeted by -5000bps in 2023.
  • Quarter analysis of 3 years shows Cullinan Therapeutics' Return on Equity stood at 0.15% in 2021, then soared by 226bps to 0.19% in 2022, then tumbled by -266bps to 0.32% in 2023.
  • Its Return on Equity stands at 0.32% for Q3 2023, versus 0.29% for Q2 2023 and 0.13% for Q1 2023.